Boston Scientific's device shows promise in restoring normal heart rhythms

09/3/2013 | MassDevice.com (Boston)

A study of 330 patients implanted with Boston Scientific's subcutaneous implantable cardiac defibrillator found that the device successfully restored normal heart rhythms in 38 patients who suffered heart irregularity during an 11-month evaluation period. The device also reversed heart rhythm irregularity 100% of the time, surpassing the FDA target of an 88% response rate, when researchers tested it by causing an abnormal heart rhythm, according to the study in the journal Circulation.

View Full Article in:

MassDevice.com (Boston)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Corporate Counsel - Regulatory Law
Regeneron
Tarrytown, NY
Program Coordinator/Lecturer for the Regulatory Science program
Johns Hopkins University
Washington, DC
Senior Attorney
Blue Cross Blue Shield of Louisiana
Baton Rouge, LA
Senior or Principal Consultant
PAREXEL International
Nationwide, SL_Nationwide
Chief Financial Officer
Health Alliance Plan of Michigan
Southfield, MI